Metrotab vet. Flavoured 1000 mg tablets for dogs

Riik: Iirimaa

keel: inglise

Allikas: HPRA (Health Products Regulatory Authority)

Osta kohe

Toote omadused Toote omadused (SPC)
15-05-2021
DSU DSU (DSU)
16-10-2023

Toimeaine:

Metronidazole

Saadav alates:

CP-Pharma Handelsgesellschaft mbH

ATC kood:

QP51AA01

INN (Rahvusvaheline Nimetus):

Metronidazole

Annus:

1000 mg/tablet

Ravimvorm:

Tablet

Retsepti tüüp:

POM: Prescription Only Medicine as defined in relevant national legislation

Terapeutiline ala:

metronidazole

Volitamisolek:

Authorised

Loa andmise kuupäev:

2021-05-14

Toote omadused

                                Health Products Regulatory Authority
14 May 2021
CRN009N5Z
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Metrotab vet. Flavoured 1000 mg tablets for dogs
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains:
ACTIVE SUBSTANCE:​
​
​
Metronidazole
​
1000 mg
EXCIPIENTS:
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Tablet.
Off-white to light brown with brown spots, round and convex flavoured
tablet with a cross-shaped break line on one side.
The tablets can be divided into 2 or 4 equal parts.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of gastrointestinal tract infections caused by _Giardia
_spp. and _Clostridia _spp. (i.e. _C. perfringens _or _C. difficile_).
Treatment of infections of the urogenital tract, oral cavity, throat
and skin caused by obligate anaerobic bacteria (e.g. _Clostridia _
spp.) susceptible to metronidazole.
4.3 CONTRAINDICATIONS
Do not use in cases of hepatic disorders.
Do not use in known cases of hypersensitivity to the active substance
or to any of the excipients.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Due to the likely variability (time, geographical) in the occurrence
of metronidazole resistant bacteria, bacteriological sampling
and susceptibility testing are recommended.
Whenever possible, the product should only be used based on
susceptibility testing.
Official, national and regional antimicrobial policies should be taken
into account when the veterinary medicinal product is
used.
Especially after prolonged treatment with metronidazole neurological
signs could occur.
As tablets are flavoured, store tablets out of reach of the animals in
order to avoid accidental ingestion.
Health Products Regulatory Authority
14 May 2021
CRN009N5Z
Page 2 of 5
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Metroni
                                
                                Lugege kogu dokumenti